NCT01823965

Intravitreal Injections of Ranibizumab With Deferred Laser Grid Laser Photocoagulation for Treatment of Diabetic Macular Edema With Visual Impairment

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 35 (actual)
• Sponsor: Poitiers University Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

In the prospective monocentric open label trial patients with diabetic macular edema will be treated with intravitreal injections of ranibizumab given for 3 months then with laser grid at month 4. During follow-up a ranibizumab injection will be performed every 2 months in case of best-corrected visual acuity decreased more than 5 letters.

Conditions

• Diabetic Macular Edema

Interventions

Type	Name	Description
DRUG	ranibizumab

Timeline

• Start date: 2011-10-01
• Primary completion: 2014-07-01
• Completion: 2014-07-01
• First posted: 2013-04-04
• Last updated: 2016-03-30

Locations

1 site across 1 country: France